In addition, LILRB1 has also been linked to metabolic pathways, including cholesterol homeostasis and ferroptosis resistance in malignancies such as multiple myeloma, underscoring its functional relevance beyond transplant immunology and highlighting its potential as a target for novel therapeutic strategies (92). This evidence concerns the gene LILRB1 and plasma cell myeloma.